Atypical Neurofibroma

• CLINICAL_TRIALS research · 2026-01-12
  Clinical Trial Update: Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

  This Johns Hopkins University study is developing multi-parameter biomarkers to predict malignant transformation in Neurofibromatosis type 1…

• CLINICAL_TRIALS research · 2026-01-09
  Clinical Trial Update: Neurofibromatosis Type 1 Tumor Early Detection Study

  This clinical trial update announces a study for early detection of tumors in Neurofibromatosis Type 1, and the study is currently recruitin…

• CLINICAL_TRIALS research · 2025-07-03
  Clinical Trial Update: Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST [Phase 1, Phase 2]

  An early-phase clinical trial is evaluating the combination of a MEK inhibitor and an MDM2 inhibitor in patients with Neurofibromatosis type…